frovatriptan succinate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
8 FDA-registered drug labelers
Alivus Life Sciences Limited
Almac Pharma Services Limited
Amneal Pharmaceuticals NY LLC
Glenmark Pharmaceuticals Inc., USA
Ingenus Pharmaceuticals, LLC
MYLAN LABORATORIES LIMITED
Sionc Pharmaceutical Private Limited
Viyash Life Sciences Private Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Frovatriptan
- •frovatriptan succinate
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Frovatriptan Succinate Tablet
11/12/2025to be discontinued
Frovatriptan Succinate Tablet
02/24/2026Chemical Identity
CAS158930-17-7
PubChem CID152943
DTXSIDDTXSID2049056
FormulaC18H25N3O6
Mol. Weight379.4 g/mol
SMILESCNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
Data Sources
1529432026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/frovatriptan succinate/cids/JSON
Archive: data/sources/pubchem_name/frovatriptan succinate.json
CAS 158930-17-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 158930-17-72026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json